Advances in diabetes care, research on new-onset diabetes and COVID-19 top 2022 news
Click Here to Manage Email Alerts
Healio and Endocrine Today editors have compiled the top diabetes news from 2022.
Readers were most interested in a cover story examining changes in diabetes management over 20 years, how traditional Indian medicine can inform diet choices for people with diabetes and research on the link between diabetes and COVID-19.
Here are 10 of Healio’s most-read diabetes stories from 2022.
Technology, unexpected study findings redefine diabetes management over 20 years
To celebrate its 20th anniversary, Endocrine Today published a series of articles looking back at the biggest changes in endocrinology over the past two decades. The first article in the series looked at the biggest changes with diabetes management since 2002.
What traditional Indian medicine teaches about eating well with diabetes
In a Diabetes in Real Life column published in August, Susan Weiner, MS, RDN, CDCES, FADCES, spoke with Parul Kharod, MS, RD, LDN, about the ancient medical knowledge system known as Ayurveda and what it can reveal about living with diabetes.
Eating potatoes in morning, vegetables in evening lowers mortality risk in diabetes
A study published in The Journal of Clinical Endocrinology & Metabolism revealed the time of day certain types of foods are eaten can affect mortality risk for adults with diabetes. A lower risk for mortality was observed in adults eating more potatoes in the morning and vegetables in the evening.
Time-restricted eating decreases glucose, improves time in range in type 2 diabetes
Adults with type 2 diabetes may have better glycemic control with a time-restricted eating pattern. In findings published in Diabetologia, adults with type 2 diabetes adhering to a time-restricted eating window of 10 hours had higher time in range than controls.
SURPASS-5: Tirzepatide lowers HbA1c in adults with type 2 diabetes on insulin glargine
Findings from the SURPASS-5 clinical trial revealed tirzepatide (Mounjaro, Eli Lilly) provides benefits for adults with type 2 diabetes on insulin glargine. In the trial, adults using tirzepatide had greater reductions in HbA1c and body weight compared with placebo.
40% of new-onset diabetes during COVID-19 remitted at 1 year
In a study published in the Journal of Diabetes and Its Complications, about 4% of adults hospitalized with COVID-19 early in the pandemic were diagnosed with new-onset diabetes. However, at 1 year, about 40% of those with newly diagnosed diabetes returned to normoglycemia or prediabetes.
Children with COVID-19 more likely to receive new diabetes diagnosis
In data from more than 2 million U.S. children, those who were diagnosed with COVID-19 in the first 16 months of the pandemic were more likely to be diagnosed with new-onset diabetes than those who did not contract COVID-19.
Drinking coffee may help preserve kidney function in adults with type 2 diabetes
Adults with type 2 diabetes who drink coffee may have better kidney function than non-coffee drinkers, according to study findings from Japan. In the study, coffee drinkers had a lower risk for estimated glomerular filtration rate decline and less annual change in eGFR than those who did not drink coffee.
First patient gains insulin independence with novel stem cell-derived islet cell therapy
In a presentation at the 2022 American Diabetes Association Scientific Sessions, data from a proof-of-concept study revealed a man with long-standing type 1 diabetes and no endogenous insulin production achieved insulin independence with an investigational stem cell-derived pancreatic islet cell therapy
CGM ‘becoming standard of care’ in diabetes management, with or without insulin use
A speaker at the 2022 Cardiometabolic Health Congress discussed how continuous glucose monitoring is becoming an essential part of diabetes management. Irl B. Hirsch, MD, discussed how using CGM is a well-established therapy for type 2 diabetes, but education and training is crucial to its success.
Collapse
Healio Coverage
Read more about
Click Here to Manage Email Alerts